img

Global Mebeverine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Mebeverine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Mebeverine is a drug used to alleviate some of the symptoms of irritable bowel syndrome. It works by relaxing the muscles in and around the gut.
Mebeverine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Mebeverine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Mebeverine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Mebeverine key manufacturers include Abbott, Mylan, Greville Investing Limited, Expanscience, Berlin Pharmaceutical, Eipico Pharmaceutical, Sopharma, USV Private Limited and Puren Pharma, etc. Abbott, Mylan, Greville Investing Limited are top 3 players and held % sales share in total in 2022.
Mebeverine can be divided into Capsule and Tablet, etc. Capsule is the mainstream product in the market, accounting for % sales share globally in 2022.
Mebeverine is widely used in various fields, such as Hospital, Drug Store and On-line,, etc. Hospital provides greatest supports to the Mebeverine industry development. In 2022, global % sales of Mebeverine went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mebeverine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Abbott
Mylan
Greville Investing Limited
Expanscience
Berlin Pharmaceutical
Eipico Pharmaceutical
Sopharma
USV Private Limited
Puren Pharma
Pharco
Swiss Pharm
Dr. Reddy's
Aurovitas Pharma
Segment by Type
Capsule
Tablet

Segment by Application


Hospital
Drug Store
On-line

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Mebeverine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Mebeverine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Mebeverine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Mebeverine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Mebeverine introduction, etc. Mebeverine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Mebeverine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Mebeverine Market Overview
1.1 Mebeverine Product Overview
1.2 Mebeverine Market Segment by Type
1.2.1 Capsule
1.2.2 Tablet
1.3 Global Mebeverine Market Size by Type
1.3.1 Global Mebeverine Market Size Overview by Type (2024-2034)
1.3.2 Global Mebeverine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Mebeverine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Mebeverine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Mebeverine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Mebeverine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Mebeverine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Mebeverine Sales Breakdown by Type (2024-2024)
2 Global Mebeverine Market Competition by Company
2.1 Global Top Players by Mebeverine Sales (2024-2024)
2.2 Global Top Players by Mebeverine Revenue (2024-2024)
2.3 Global Top Players by Mebeverine Price (2024-2024)
2.4 Global Top Manufacturers Mebeverine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Mebeverine Market Competitive Situation and Trends
2.5.1 Mebeverine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Mebeverine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mebeverine as of 2022)
2.7 Date of Key Manufacturers Enter into Mebeverine Market
2.8 Key Manufacturers Mebeverine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Mebeverine Status and Outlook by Region
3.1 Global Mebeverine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Mebeverine Historic Market Size by Region
3.2.1 Global Mebeverine Sales in Volume by Region (2024-2024)
3.2.2 Global Mebeverine Sales in Value by Region (2024-2024)
3.2.3 Global Mebeverine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Mebeverine Forecasted Market Size by Region
3.3.1 Global Mebeverine Sales in Volume by Region (2024-2034)
3.3.2 Global Mebeverine Sales in Value by Region (2024-2034)
3.3.3 Global Mebeverine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Mebeverine by Application
4.1 Mebeverine Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.1.3 On-line
4.2 Global Mebeverine Market Size by Application
4.2.1 Global Mebeverine Market Size Overview by Application (2024-2034)
4.2.2 Global Mebeverine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Mebeverine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Mebeverine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Mebeverine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Mebeverine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Mebeverine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Mebeverine Sales Breakdown by Application (2024-2024)
5 North America Mebeverine by Country
5.1 North America Mebeverine Historic Market Size by Country
5.1.1 North America Mebeverine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Mebeverine Sales in Volume by Country (2024-2024)
5.1.3 North America Mebeverine Sales in Value by Country (2024-2024)
5.2 North America Mebeverine Forecasted Market Size by Country
5.2.1 North America Mebeverine Sales in Volume by Country (2024-2034)
5.2.2 North America Mebeverine Sales in Value by Country (2024-2034)
6 Europe Mebeverine by Country
6.1 Europe Mebeverine Historic Market Size by Country
6.1.1 Europe Mebeverine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Mebeverine Sales in Volume by Country (2024-2024)
6.1.3 Europe Mebeverine Sales in Value by Country (2024-2024)
6.2 Europe Mebeverine Forecasted Market Size by Country
6.2.1 Europe Mebeverine Sales in Volume by Country (2024-2034)
6.2.2 Europe Mebeverine Sales in Value by Country (2024-2034)
7 Asia-Pacific Mebeverine by Region
7.1 Asia-Pacific Mebeverine Historic Market Size by Region
7.1.1 Asia-Pacific Mebeverine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Mebeverine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Mebeverine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Mebeverine Forecasted Market Size by Region
7.2.1 Asia-Pacific Mebeverine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Mebeverine Sales in Value by Region (2024-2034)
8 Latin America Mebeverine by Country
8.1 Latin America Mebeverine Historic Market Size by Country
8.1.1 Latin America Mebeverine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Mebeverine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Mebeverine Sales in Value by Country (2024-2024)
8.2 Latin America Mebeverine Forecasted Market Size by Country
8.2.1 Latin America Mebeverine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Mebeverine Sales in Value by Country (2024-2034)
9 Middle East and Africa Mebeverine by Country
9.1 Middle East and Africa Mebeverine Historic Market Size by Country
9.1.1 Middle East and Africa Mebeverine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Mebeverine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Mebeverine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Mebeverine Forecasted Market Size by Country
9.2.1 Middle East and Africa Mebeverine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Mebeverine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Abbott Mebeverine Products Offered
10.1.5 Abbott Recent Development
10.2 Mylan
10.2.1 Mylan Company Information
10.2.2 Mylan Introduction and Business Overview
10.2.3 Mylan Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Mylan Mebeverine Products Offered
10.2.5 Mylan Recent Development
10.3 Greville Investing Limited
10.3.1 Greville Investing Limited Company Information
10.3.2 Greville Investing Limited Introduction and Business Overview
10.3.3 Greville Investing Limited Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Greville Investing Limited Mebeverine Products Offered
10.3.5 Greville Investing Limited Recent Development
10.4 Expanscience
10.4.1 Expanscience Company Information
10.4.2 Expanscience Introduction and Business Overview
10.4.3 Expanscience Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Expanscience Mebeverine Products Offered
10.4.5 Expanscience Recent Development
10.5 Berlin Pharmaceutical
10.5.1 Berlin Pharmaceutical Company Information
10.5.2 Berlin Pharmaceutical Introduction and Business Overview
10.5.3 Berlin Pharmaceutical Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Berlin Pharmaceutical Mebeverine Products Offered
10.5.5 Berlin Pharmaceutical Recent Development
10.6 Eipico Pharmaceutical
10.6.1 Eipico Pharmaceutical Company Information
10.6.2 Eipico Pharmaceutical Introduction and Business Overview
10.6.3 Eipico Pharmaceutical Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Eipico Pharmaceutical Mebeverine Products Offered
10.6.5 Eipico Pharmaceutical Recent Development
10.7 Sopharma
10.7.1 Sopharma Company Information
10.7.2 Sopharma Introduction and Business Overview
10.7.3 Sopharma Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Sopharma Mebeverine Products Offered
10.7.5 Sopharma Recent Development
10.8 USV Private Limited
10.8.1 USV Private Limited Company Information
10.8.2 USV Private Limited Introduction and Business Overview
10.8.3 USV Private Limited Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 USV Private Limited Mebeverine Products Offered
10.8.5 USV Private Limited Recent Development
10.9 Puren Pharma
10.9.1 Puren Pharma Company Information
10.9.2 Puren Pharma Introduction and Business Overview
10.9.3 Puren Pharma Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Puren Pharma Mebeverine Products Offered
10.9.5 Puren Pharma Recent Development
10.10 Pharco
10.10.1 Pharco Company Information
10.10.2 Pharco Introduction and Business Overview
10.10.3 Pharco Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Pharco Mebeverine Products Offered
10.10.5 Pharco Recent Development
10.11 Swiss Pharm
10.11.1 Swiss Pharm Company Information
10.11.2 Swiss Pharm Introduction and Business Overview
10.11.3 Swiss Pharm Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Swiss Pharm Mebeverine Products Offered
10.11.5 Swiss Pharm Recent Development
10.12 Dr. Reddy's
10.12.1 Dr. Reddy's Company Information
10.12.2 Dr. Reddy's Introduction and Business Overview
10.12.3 Dr. Reddy's Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Dr. Reddy's Mebeverine Products Offered
10.12.5 Dr. Reddy's Recent Development
10.13 Aurovitas Pharma
10.13.1 Aurovitas Pharma Company Information
10.13.2 Aurovitas Pharma Introduction and Business Overview
10.13.3 Aurovitas Pharma Mebeverine Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Aurovitas Pharma Mebeverine Products Offered
10.13.5 Aurovitas Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Mebeverine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Mebeverine Industrial Chain Analysis
11.4 Mebeverine Market Dynamics
11.4.1 Mebeverine Industry Trends
11.4.2 Mebeverine Market Drivers
11.4.3 Mebeverine Market Challenges
11.4.4 Mebeverine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Mebeverine Distributors
12.3 Mebeverine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Capsule
Table 2. Major Company of Tablet
Table 3. Global Mebeverine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Mebeverine Sales by Type (2024-2024) & (K Units)
Table 5. Global Mebeverine Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Mebeverine Sales by Type (2024-2024) & (US& Million)
Table 7. Global Mebeverine Market Share in Value by Type (2024-2024)
Table 8. Global Mebeverine Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Mebeverine Sales by Type (2024-2034) & (K Units)
Table 10. Global Mebeverine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Mebeverine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Mebeverine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Mebeverine Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Mebeverine Sales by Type (2024-2024) & (K Units)
Table 15. North America Mebeverine Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Mebeverine Sales (K Units) by Type (2024-2024)
Table 17. Europe Mebeverine Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Mebeverine Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Mebeverine Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Mebeverine Sales (K Units) by Type (2024-2024)
Table 21. Latin America Mebeverine Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Mebeverine Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Mebeverine Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Mebeverine Sales by Company (2024-2024) & (K Units)
Table 25. Global Mebeverine Sales Share by Company (2024-2024)
Table 26. Global Mebeverine Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Mebeverine Revenue Share by Company (2024-2024)
Table 28. Global Market Mebeverine Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Mebeverine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Mebeverine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mebeverine as of 2022)
Table 32. Date of Key Manufacturers Enter into Mebeverine Market
Table 33. Key Manufacturers Mebeverine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Mebeverine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Mebeverine Sales by Region (2024-2024) & (K Units)
Table 37. Global Mebeverine Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Mebeverine Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Mebeverine Sales Market Share in Value by Region (2024-2024)
Table 40. Global Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Mebeverine Sales by Region (2024-2034) & (K Units)
Table 42. Global Mebeverine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Mebeverine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Mebeverine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Mebeverine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Mebeverine Sales by Application (2024-2024) & (K Units)
Table 48. Global Mebeverine Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Mebeverine Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Mebeverine Sales Market Share in Value by Application (2024-2024)
Table 51. Global Mebeverine Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Mebeverine Sales by Application (2024-2034) & (K Units)
Table 53. Global Mebeverine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Mebeverine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Mebeverine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Mebeverine Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Mebeverine Sales by Application (2024-2024) (K Units)
Table 58. North America Mebeverine Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Mebeverine Sales by Application (2024-2024) (K Units)
Table 60. Europe Mebeverine Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Mebeverine Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Mebeverine Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Mebeverine Sales by Application (2024-2024) (K Units)
Table 64. Latin America Mebeverine Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Mebeverine Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Mebeverine Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Mebeverine Sales by Country (2024-2024) & (K Units)
Table 68. North America Mebeverine Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Mebeverine Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Mebeverine Sales Market Share in Value by Country (2024-2024)
Table 71. North America Mebeverine Sales by Country (2024-2034) & (K Units)
Table 72. North America Mebeverine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Mebeverine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Mebeverine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Mebeverine Sales by Country (2024-2024) & (K Units)
Table 76. Europe Mebeverine Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Mebeverine Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Mebeverine Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Mebeverine Sales by Country (2024-2034) & (K Units)
Table 80. Europe Mebeverine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Mebeverine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Mebeverine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Mebeverine Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Mebeverine Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Mebeverine Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Mebeverine Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Mebeverine Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Mebeverine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Mebeverine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Mebeverine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Mebeverine Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Mebeverine Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Mebeverine Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Mebeverine Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Mebeverine Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Mebeverine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Mebeverine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Mebeverine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Mebeverine Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Mebeverine Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Mebeverine Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Mebeverine Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Mebeverine Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Mebeverine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Mebeverine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Mebeverine Sales Market Share in Value by Country (2024-2034)
Table 107. Abbott Company Information
Table 108. Abbott Introduction and Business Overview
Table 109. Abbott Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Abbott Mebeverine Product
Table 111. Abbott Recent Development
Table 112. Mylan Company Information
Table 113. Mylan Introduction and Business Overview
Table 114. Mylan Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Mylan Mebeverine Product
Table 116. Mylan Recent Development
Table 117. Greville Investing Limited Company Information
Table 118. Greville Investing Limited Introduction and Business Overview
Table 119. Greville Investing Limited Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Greville Investing Limited Mebeverine Product
Table 121. Greville Investing Limited Recent Development
Table 122. Expanscience Company Information
Table 123. Expanscience Introduction and Business Overview
Table 124. Expanscience Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Expanscience Mebeverine Product
Table 126. Expanscience Recent Development
Table 127. Berlin Pharmaceutical Company Information
Table 128. Berlin Pharmaceutical Introduction and Business Overview
Table 129. Berlin Pharmaceutical Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Berlin Pharmaceutical Mebeverine Product
Table 131. Berlin Pharmaceutical Recent Development
Table 132. Eipico Pharmaceutical Company Information
Table 133. Eipico Pharmaceutical Introduction and Business Overview
Table 134. Eipico Pharmaceutical Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Eipico Pharmaceutical Mebeverine Product
Table 136. Eipico Pharmaceutical Recent Development
Table 137. Sopharma Company Information
Table 138. Sopharma Introduction and Business Overview
Table 139. Sopharma Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Sopharma Mebeverine Product
Table 141. Sopharma Recent Development
Table 142. USV Private Limited Company Information
Table 143. USV Private Limited Introduction and Business Overview
Table 144. USV Private Limited Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. USV Private Limited Mebeverine Product
Table 146. USV Private Limited Recent Development
Table 147. Puren Pharma Company Information
Table 148. Puren Pharma Introduction and Business Overview
Table 149. Puren Pharma Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Puren Pharma Mebeverine Product
Table 151. Puren Pharma Recent Development
Table 152. Pharco Company Information
Table 153. Pharco Introduction and Business Overview
Table 154. Pharco Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Pharco Mebeverine Product
Table 156. Pharco Recent Development
Table 157. Swiss Pharm Company Information
Table 158. Swiss Pharm Introduction and Business Overview
Table 159. Swiss Pharm Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Swiss Pharm Mebeverine Product
Table 161. Swiss Pharm Recent Development
Table 162. Dr. Reddy's Company Information
Table 163. Dr. Reddy's Introduction and Business Overview
Table 164. Dr. Reddy's Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Dr. Reddy's Mebeverine Product
Table 166. Dr. Reddy's Recent Development
Table 167. Aurovitas Pharma Company Information
Table 168. Aurovitas Pharma Introduction and Business Overview
Table 169. Aurovitas Pharma Mebeverine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Aurovitas Pharma Mebeverine Product
Table 171. Aurovitas Pharma Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Mebeverine Market Trends
Table 175. Mebeverine Market Drivers
Table 176. Mebeverine Market Challenges
Table 177. Mebeverine Market Restraints
Table 178. Mebeverine Distributors List
Table 179. Mebeverine Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Mebeverine Product Picture
Figure 2. Global Mebeverine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Mebeverine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Mebeverine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Capsule
Figure 6. Global Capsule Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Tablet
Figure 8. Global Tablet Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Mebeverine Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Mebeverine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Mebeverine Sales Market Share in Volume by Type in 2022
Figure 12. North America Mebeverine Sales Market Share in Value by Type in 2022
Figure 13. Europe Mebeverine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Mebeverine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Mebeverine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Mebeverine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Mebeverine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Mebeverine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Mebeverine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Mebeverine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Mebeverine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Mebeverine Revenue in 2022
Figure 23. Mebeverine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Drug Store
Figure 27. Global Drug Store Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of On-line
Figure 29. Global On-line Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Mebeverine Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Mebeverine Sales Market Share by Application in 2022 & 2034
Figure 32. North America Mebeverine Sales Market Share in Volume by Application in 2022
Figure 33. North America Mebeverine Sales Market Share in Value by Application in 2022
Figure 34. Europe Mebeverine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Mebeverine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Mebeverine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Mebeverine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Mebeverine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Mebeverine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Mebeverine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Mebeverine Manufacturing Cost Structure
Figure 43. Mebeverine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries